REYVOW (lasmiditan succinate) Eli lilly and co Patent: 8,748,459 Expiration: Mar 27, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations for the We…
Drug Patent Expirations for the Week of March 26, 2023 Read Post »
Annual Drug Patent Expirations for LUMIFY Lumify is a drug marketed by Bausch And Lomb Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Bausch And drug LUMIFY appeared first on DrugPatentWatch – Make…
Annual Drug Patent Expirations for REYVOW Reyvow is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post New patent for Eli Lilly drug REYVOW appeared first on DrugPatentWatch – Make Bet…
Annual Drug Patent Expirations for ELUCIREM Elucirem is a drug marketed by Guerbet and is included in one NDA. It is available from two suppliers. There are two patents protecting…
The post New patent for Guerbet drug ELUCIREM appeared first on DrugPat…
Annual Drug Patent Expirations for SOLOSEC Solosec is a drug marketed by Lupin and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent for LUPIN drug SOLOSEC appeared first on DrugPatentWat…
Annual Drug Patent Expirations for ISENTRESS Isentress is a drug marketed by Msd Sub Merck and is included in three NDAs. It is available from eight suppliers. There are six…
The post New patent for Msd Sub drug ISENTRESS appeared first on DrugPatentWa…
This chart shows the pharmaceutical companies with patents in the most countries. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the greatest glo…
Which pharmaceutical companies have the greatest global patent coverage? Read Post »
Annual Drug Patent Expirations for VENCLEXTA Venclexta is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Abbvie Inc drug VENCLEXTA appeared first on DrugPaten…
Annual Drug Patent Expirations for INJECTAFER Injectafer is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Am Regent drug INJECTAFER appeared first on DrugPat…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Spain? Read Post »
Get new actionable insights and updates from BiotechBlog
